APO Research
Talk to an analyst

APO RESEARCH · REPORT

Cardiac AI-assisted Diagnosis

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Cardiac AI-assisted Diagnosis Industry Growth and Trends Forecast to 2032

6 March 2026113 pages

Choose your research edition.

Industry ResearchCardiac AI-assisted Diagnosis Industry Research Report 2026128 pages · $2,950 USDIndustry Growth & TrendsGlobal Cardiac AI-assisted Diagnosis Industry Growth and Trends Forecast to 2032113 pages · $3,450 USDMarket StructureGlobal Cardiac AI-assisted Diagnosis Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032198 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Cardiac AI-assisted Diagnosis Market Outlook and Growth Opportunities 2026205 pages · $4,250 USDMarket Analysis & ForecastGlobal Cardiac AI-assisted Diagnosis Market Analysis and Forecast 2026-2032200 pages · $4,950 USD

Market perspective

According to APO Research, the global Cardiac AI-assisted Diagnosis market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Cardiac AI-assisted Diagnosis is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Cardiac AI-assisted Diagnosis is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Cardiac AI-assisted Diagnosis is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global companies in the Cardiac AI-assisted Diagnosis market include Lepu Medical, G K Healthcare, Sense Time, United Imaging, Infervision, Shukun, FOSUN AITROX, NANO-X and MyCardium AI, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Cardiac AI-assisted Diagnosis market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Cardiac AI-assisted Diagnosis market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Cardiac AI-assisted Diagnosis market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Cardiac AI-assisted Diagnosis.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading companies in the global Cardiac AI-assisted Diagnosis market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Cardiac AI-assisted Diagnosis Market by Company

Lepu Medical

G K Healthcare

Sense Time

United Imaging

Infervision

Shukun

FOSUN AITROX

NANO-X

MyCardium AI

VUNO

Caption Care

UltraSight

Ultromics

Cleerly

Elucid

DiA Imaging Analysis

Koninklijke Philips N.V

Fujifilm

Cardiac AI-assisted Diagnosis Segment by Type

Cloud-based

On-Primes

Cardiac AI-assisted Diagnosis Segment by Application

Hospital

Clinic

Imaging Center

Cardiac AI-assisted Diagnosis Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Cardiac AI-assisted Diagnosis market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Cardiac AI-assisted Diagnosis and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Cardiac AI-assisted Diagnosis.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 5: Detailed analysis of Cardiac AI-assisted Diagnosis companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.

Chapter 12: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Global Cardiac AI-assisted Diagnosis Market Size (US$ Million) Comparison by Region: 2021 VS 2025 VS 2032 Table 2. Global Cardiac AI-assisted Diagnosis Market Size by Region (2021-2026) & (US$ Million) Table 3. Global Cardiac AI-assisted Diagnosis Market Share by Region (2021-2026) Table 4. Global Cardiac AI-assisted Diagnosis Market Size by Region (2027-2032) & (US$ Million) Table 5. Global Cardiac AI-assisted Diagnosis Market Share by Region (2027-2032) Table 6. Global Cardiac AI-assisted Diagnosis Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 7. Global Cardiac AI-assisted Diagnosis Market Size by Type (2021-2026) & (US$ Million) Table 8. Global Cardiac AI-assisted Diagnosis Market Size Share by Type (2021-2026) Table 9. Global Cardiac AI-assisted Diagnosis Market Size Forecasted by Type (2027-2032) & (US$ Million) Table 10. Global Cardiac AI-assisted Diagnosis Market Size Share Forecasted by Type (2027-2032) Table 11. North America Cardiac AI-assisted Diagnosis Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 12. North America Cardiac AI-assisted Diagnosis Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 13. Europe Cardiac AI-assisted Diagnosis Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 14. Europe Cardiac AI-assisted Diagnosis Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 15. Asia-Pacific Cardiac AI-assisted Diagnosis Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 16. Asia-Pacific Cardiac AI-assisted Diagnosis Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 17. Latin America Cardiac AI-assisted Diagnosis Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 18. Latin America Cardiac AI-assisted Diagnosis Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 19. Middle East and Africa Cardiac AI-assisted Diagnosis Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 20. Middle East and Africa Cardiac AI-assisted Diagnosis Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 21. Global Cardiac AI-assisted Diagnosis Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 22. Global Cardiac AI-assisted Diagnosis Market Size by Application (2021-2026) & (US$ Million) Table 23. Global Cardiac AI-assisted Diagnosis Market Size Share by Application (2021-2026) Table 24. Global Cardiac AI-assisted Diagnosis Market Size Forecasted by Application (2027-2032) & (US$ Million) Table 25. Global Cardiac AI-assisted Diagnosis Market Size Share Forecasted by Application (2027-2032) Table 26. North America Cardiac AI-assisted Diagnosis Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 27. North America Cardiac AI-assisted Diagnosis Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 28. Europe Cardiac AI-assisted Diagnosis Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 29. Europe Cardiac AI-assisted Diagnosis Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 30. Asia-Pacific Cardiac AI-assisted Diagnosis Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 31. Asia-Pacific Cardiac AI-assisted Diagnosis Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 32. Latin America Cardiac AI-assisted Diagnosis Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 33. Latin America Cardiac AI-assisted Diagnosis Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 34. Middle East and Africa Cardiac AI-assisted Diagnosis Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 35. Middle East and Africa Cardiac AI-assisted Diagnosis Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 36. Cardiac AI-assisted Diagnosis Industry Trends Table 37. Cardiac AI-assisted Diagnosis Industry Drivers Table 38. Cardiac AI-assisted Diagnosis Industry Opportunities and Challenges Table 39. Cardiac AI-assisted Diagnosis Industry Restraints Table 40. Global Cardiac AI-assisted Diagnosis Revenue by Company (US$ Million) & (2021-2026) Table 41. Global Cardiac AI-assisted Diagnosis Revenue Market Share by Company (2021-2026) Table 42. Global Cardiac AI-assisted Diagnosis Industry Company Ranking, 2024 VS 2025 VS 2026 Table 43. Global Cardiac AI-assisted Diagnosis Key Company Headquarters & Area Served Table 44. Global Cardiac AI-assisted Diagnosis Company, Product Type & Application Table 45. Global Cardiac AI-assisted Diagnosis Company Commercialization Time Table 46. Global Company Market Concentration Ratio (CR5 and HHI) Table 47. Global Cardiac AI-assisted Diagnosis by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 48. Lepu Medical Company Information Table 49. Lepu Medical Business Overview Table 50. Lepu Medical Cardiac AI-assisted Diagnosis Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 51. Lepu Medical Cardiac AI-assisted Diagnosis Product Portfolio Table 52. Lepu Medical Recent Development Table 53. G K Healthcare Company Information Table 54. G K Healthcare Business Overview Table 55. G K Healthcare Cardiac AI-assisted Diagnosis Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 56. G K Healthcare Cardiac AI-assisted Diagnosis Product Portfolio Table 57. G K Healthcare Recent Development Table 58. Sense Time Company Information Table 59. Sense Time Business Overview Table 60. Sense Time Cardiac AI-assisted Diagnosis Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 61. Sense Time Cardiac AI-assisted Diagnosis Product Portfolio Table 62. Sense Time Recent Development Table 63. United Imaging Company Information Table 64. United Imaging Business Overview Table 65. United Imaging Cardiac AI-assisted Diagnosis Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 66. United Imaging Cardiac AI-assisted Diagnosis Product Portfolio Table 67. United Imaging Recent Development Table 68. Infervision Company Information Table 69. Infervision Business Overview Table 70. Infervision Cardiac AI-assisted Diagnosis Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 71. Infervision Cardiac AI-assisted Diagnosis Product Portfolio Table 72. Infervision Recent Development Table 73. Shukun Company Information Table 74. Shukun Business Overview Table 75. Shukun Cardiac AI-assisted Diagnosis Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 76. Shukun Cardiac AI-assisted Diagnosis Product Portfolio Table 77. Shukun Recent Development Table 78. FOSUN AITROX Company Information Table 79. FOSUN AITROX Business Overview Table 80. FOSUN AITROX Cardiac AI-assisted Diagnosis Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 81. FOSUN AITROX Cardiac AI-assisted Diagnosis Product Portfolio Table 82. FOSUN AITROX Recent Development Table 83. NANO-X Company Information Table 84. NANO-X Business Overview Table 85. NANO-X Cardiac AI-assisted Diagnosis Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 86. NANO-X Cardiac AI-assisted Diagnosis Product Portfolio Table 87. NANO-X Recent Development Table 88. MyCardium AI Company Information Table 89. MyCardium AI Business Overview Table 90. MyCardium AI Cardiac AI-assisted Diagnosis Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 91. MyCardium AI Cardiac AI-assisted Diagnosis Product Portfolio Table 92. MyCardium AI Recent Development Table 93. VUNO Company Information Table 94. VUNO Business Overview Table 95. VUNO Cardiac AI-assisted Diagnosis Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 96. VUNO Cardiac AI-assisted Diagnosis Product Portfolio Table 97. VUNO Recent Development Table 98. Caption Care Company Information Table 99. Caption Care Business Overview Table 100. Caption Care Cardiac AI-assisted Diagnosis Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 101. Caption Care Cardiac AI-assisted Diagnosis Product Portfolio Table 102. Caption Care Recent Development Table 103. UltraSight Company Information Table 104. UltraSight Business Overview Table 105. UltraSight Cardiac AI-assisted Diagnosis Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 106. UltraSight Cardiac AI-assisted Diagnosis Product Portfolio Table 107. UltraSight Recent Development Table 108. Ultromics Company Information Table 109. Ultromics Business Overview Table 110. Ultromics Cardiac AI-assisted Diagnosis Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 111. Ultromics Cardiac AI-assisted Diagnosis Product Portfolio Table 112. Ultromics Recent Development Table 113. Cleerly Company Information Table 114. Cleerly Business Overview Table 115. Cleerly Cardiac AI-assisted Diagnosis Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 116. Cleerly Cardiac AI-assisted Diagnosis Product Portfolio Table 117. Cleerly Recent Development Table 118. Elucid Company Information Table 119. Elucid Business Overview Table 120. Elucid Cardiac AI-assisted Diagnosis Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 121. Elucid Cardiac AI-assisted Diagnosis Product Portfolio Table 122. Elucid Recent Development Table 123. DiA Imaging Analysis Company Information Table 124. DiA Imaging Analysis Business Overview Table 125. DiA Imaging Analysis Cardiac AI-assisted Diagnosis Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 126. DiA Imaging Analysis Cardiac AI-assisted Diagnosis Product Portfolio Table 127. DiA Imaging Analysis Recent Development Table 128. Koninklijke Philips N.V Company Information Table 129. Koninklijke Philips N.V Business Overview Table 130. Koninklijke Philips N.V Cardiac AI-assisted Diagnosis Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 131. Koninklijke Philips N.V Cardiac AI-assisted Diagnosis Product Portfolio Table 132. Koninklijke Philips N.V Recent Development Table 133. Fujifilm Company Information Table 134. Fujifilm Business Overview Table 135. Fujifilm Cardiac AI-assisted Diagnosis Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 136. Fujifilm Cardiac AI-assisted Diagnosis Product Portfolio Table 137. Fujifilm Recent Development Table 138. North America Cardiac AI-assisted Diagnosis Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 139. North America Cardiac AI-assisted Diagnosis Market Size by Country (2021-2026) & (US$ Million) Table 140. North America Cardiac AI-assisted Diagnosis Market Share by Country (2021-2026) Table 141. North America Cardiac AI-assisted Diagnosis Market Size Forecast by Country (2027-2032) & (US$ Million) Table 142. North America Cardiac AI-assisted Diagnosis Market Share Forecast by Country (2027-2032) Table 143. Europe Cardiac AI-assisted Diagnosis Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 144. Europe Cardiac AI-assisted Diagnosis Market Size by Country (2021-2026) & (US$ Million) Table 145. Europe Cardiac AI-assisted Diagnosis Market Share by Country (2021-2026) Table 146. Europe Cardiac AI-assisted Diagnosis Market Size Forecast by Country (2027-2032) & (US$ Million) Table 147. Europe Cardiac AI-assisted Diagnosis Market Share Forecast by Country (2027-2032) Table 148. Asia-Pacific Cardiac AI-assisted Diagnosis Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 149. Asia-Pacific Cardiac AI-assisted Diagnosis Market Size by Country (2021-2026) & (US$ Million) Table 150. Asia-Pacific Cardiac AI-assisted Diagnosis Market Share by Country (2021-2026) Table 151. Asia-Pacific Cardiac AI-assisted Diagnosis Market Size Forecast by Country (2027-2032) & (US$ Million) Table 152. Asia-Pacific Cardiac AI-assisted Diagnosis Market Share Forecast by Country (2027-2032) Table 153. Latin America Cardiac AI-assisted Diagnosis Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 154. Latin America Cardiac AI-assisted Diagnosis Market Size by Country (2021-2026) & (US$ Million) Table 155. Latin America Cardiac AI-assisted Diagnosis Market Share by Country (2021-2026) Table 156. Latin America Cardiac AI-assisted Diagnosis Market Size Forecast by Country (2027-2032) & (US$ Million) Table 157. Latin America Cardiac AI-assisted Diagnosis Market Share Forecast by Country (2027-2032) Table 158. Middle East & Africa Cardiac AI-assisted Diagnosis Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 159. Middle East & Africa Cardiac AI-assisted Diagnosis Market Size by Country (2021-2026) & (US$ Million) Table 160. Middle East & Africa Cardiac AI-assisted Diagnosis Market Share by Country (2021-2026) Table 161. Middle East & Africa Cardiac AI-assisted Diagnosis Market Size Forecast by Country (2027-2032) & (US$ Million) Table 162. Middle East & Africa Cardiac AI-assisted Diagnosis Market Share Forecast by Country (2027-2032) Table 163. Research Programs/Design for This Report Table 164. Authors List of This Report Table 165. Secondary Sources List of Figures Figure 1.List of Figures Figure 2. Cardiac AI-assisted Diagnosis Product Image Figure 3. Global Cardiac AI-assisted Diagnosis Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 4. Global Cardiac AI-assisted Diagnosis Market Size (2021-2032) & (US$ Million) Figure 5. Global Cardiac AI-assisted Diagnosis Market Share by Region: 2025 VS 2032 Figure 6. Global Cardiac AI-assisted Diagnosis Market Share by Region (2021-2032) Figure 7. North America Cardiac AI-assisted Diagnosis Market Size Growth Rate (2021-2032) & (US$ Million) Figure 8. Europe Cardiac AI-assisted Diagnosis Market Size Growth Rate (2021-2032) & (US$ Million) Figure 9. Asia-Pacific Cardiac AI-assisted Diagnosis Market Size Growth Rate (2021-2032) & (US$ Million) Figure 10. Latin America Cardiac AI-assisted Diagnosis Market Size Growth Rate (2021-2032) & (US$ Million) Figure 11. Middle East & Africa Cardiac AI-assisted Diagnosis Market Size Growth Rate (2021-2032) & (US$ Million) Figure 12. Cloud-based Image Figure 13. Global Cloud-based Market Size YoY Growth (2021-2032) & (US$ Million) Figure 14. On-Primes Image Figure 15. Global On-Primes Market Size YoY Growth (2021-2032) & (US$ Million) Figure 16. Global Cardiac AI-assisted Diagnosis Market Size Overview by Type (2021-2032) & (US$ Million) Figure 17. Global Cardiac AI-assisted Diagnosis Market Share by Type 2025 VS 2032 Figure 18. North America Cardiac AI-assisted Diagnosis Market Size Share by Type (2021-2032) Figure 19. Europe Cardiac AI-assisted Diagnosis Market Size Share by Type (2021-2032) Figure 20. Asia-Pacific Cardiac AI-assisted Diagnosis Market Size Share by Type (2021-2032) Figure 21. Latin America Cardiac AI-assisted Diagnosis Market Size Share by Type (2021-2032) Figure 22. Middle East and Africa Cardiac AI-assisted Diagnosis Market Size Share by Type (2021-2032) Figure 23. Hospital Image Figure 24. Global Hospital Market Size YoY Growth (2021-2032) & (US$ Million) Figure 25. Clinic Image Figure 26. Global Clinic Market Size YoY Growth (2021-2032) & (US$ Million) Figure 27. Imaging Center Image Figure 28. Global Imaging Center Market Size YoY Growth (2021-2032) & (US$ Million) Figure 29. Global Cardiac AI-assisted Diagnosis Market Size Overview by Application (2021-2032) & (US$ Million) Figure 30. Global Cardiac AI-assisted Diagnosis Market Share by Application 2025 VS 2032 Figure 31. North America Cardiac AI-assisted Diagnosis Market Size Share by Application (2021-2032) Figure 32. Europe Cardiac AI-assisted Diagnosis Market Size Share by Application (2021-2032) Figure 33. Asia-Pacific Cardiac AI-assisted Diagnosis Market Size Share by Application (2021-2032) Figure 34. Latin America Cardiac AI-assisted Diagnosis Market Size Share by Application (2021-2032) Figure 35. Middle East and Africa Cardiac AI-assisted Diagnosis Market Size Share by Application (2021-2032) Figure 36. Global Top 5 and 10 Cardiac AI-assisted Diagnosis Players Market Share by Revenue in 2025 Figure 37. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 38. North America Cardiac AI-assisted Diagnosis Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 39. North America Cardiac AI-assisted Diagnosis Market Share by Country: 2021 VS 2025 VS 2032 Figure 40. North America Cardiac AI-assisted Diagnosis Market Share by Country (2021-2032) Figure 41. Europe Cardiac AI-assisted Diagnosis Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 42. Europe Cardiac AI-assisted Diagnosis Market Share by Country: 2021 VS 2025 VS 2032 Figure 43. Europe Cardiac AI-assisted Diagnosis Market Share by Country (2021-2032) Figure 44. Asia-Pacific Cardiac AI-assisted Diagnosis Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 45. Asia-Pacific Cardiac AI-assisted Diagnosis Market Share by Country: 2021 VS 2025 VS 2032 Figure 46. Asia-Pacific Cardiac AI-assisted Diagnosis Market Share by Country (2021-2032) Figure 47. Latin America Cardiac AI-assisted Diagnosis Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. Latin America Cardiac AI-assisted Diagnosis Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Latin America Cardiac AI-assisted Diagnosis Market Share by Country (2021-2032) Figure 50. Middle East & Africa Cardiac AI-assisted Diagnosis Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 51. Middle East & Africa Cardiac AI-assisted Diagnosis Market Share by Country: 2021 VS 2025 VS 2032 Figure 52. Middle East & Africa Cardiac AI-assisted Diagnosis Market Share by Country (2021-2032) Figure 53. Years Considered Figure 54. Research Process Figure 55. Key Executives Interviewed

Scope & coverage.

Types
  • Cloud-based
  • On-Primes
Applications
  • Hospital
  • Clinic
  • Imaging Center
Companies covered
  • Lepu Medical
  • G K Healthcare
  • Sense Time
  • United Imaging
  • Infervision
  • Shukun
  • FOSUN AITROX
  • NANO-X
  • MyCardium AI
  • VUNO
  • Caption Care
  • UltraSight
  • Ultromics
  • Cleerly
  • Elucid
  • DiA Imaging Analysis
  • Koninklijke Philips N.V
  • Fujifilm

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.3 Global Cardiac AI-assisted Diagnosis Market Size Overview by Region 2021 VS 2025 VS 2032
  4. 1.4 Global Cardiac AI-assisted Diagnosis Market Size by Region (2021-2032)
  5. 1.4.1 Global Cardiac AI-assisted Diagnosis Market Size by Region (2021-2026)
  6. 1.4.2 Global Cardiac AI-assisted Diagnosis Market Size by Region (2027-2032)
  7. 1.5 Key Regions Cardiac AI-assisted Diagnosis Market Size (2021-2032)
  8. 1.5.1 North America Cardiac AI-assisted Diagnosis Market Size Growth Rate (2021-2032)
  9. 1.5.2 Europe Cardiac AI-assisted Diagnosis Market Size Growth Rate (2021-2032)
  10. 1.5.3 Asia-Pacific Cardiac AI-assisted Diagnosis Market Size Growth Rate (2021-2032)
  11. 1.5.4 South America Cardiac AI-assisted Diagnosis Market Size Growth Rate (2021-2032)
  12. 1.5.5 Middle East & Africa Cardiac AI-assisted Diagnosis Market Size Growth Rate (2021-2032)
2 Cardiac AI-assisted Diagnosis Market by Type
  1. 2.1 Type Introduction
  2. 2.1.1 Cloud-based
  3. 2.1.2 On-Primes
  4. 2.2 Global Cardiac AI-assisted Diagnosis Market Size by Type
  5. 2.2.1 Global Cardiac AI-assisted Diagnosis Market Size Overview by Type (2021-2032)
  6. 2.2.2 Global Cardiac AI-assisted Diagnosis Historic Market Size Review by Type (2021-2026)
  7. 2.2.3 Global Cardiac AI-assisted Diagnosis Market Size Forecasted by Type (2027-2032)
  8. 2.3 Global Cardiac AI-assisted Diagnosis Market Size by Regions
  9. 2.3.1 North America Cardiac AI-assisted Diagnosis Market Size Breakdown by Type (2021-2026)
  10. 2.3.2 Europe Cardiac AI-assisted Diagnosis Market Size Breakdown by Type (2021-2026)
  11. 2.3.3 Asia-Pacific Cardiac AI-assisted Diagnosis Market Size Breakdown by Type (2021-2026)
  12. 2.3.4 South America Cardiac AI-assisted Diagnosis Market Size Breakdown by Type (2021-2026)
  13. 2.3.5 Middle East and Africa Cardiac AI-assisted Diagnosis Market Size Breakdown by Type (2021-2026)
3 Cardiac AI-assisted Diagnosis Market by Application
  1. 3.1 Type Introduction
  2. 3.1.1 Hospital
  3. 3.1.2 Clinic
  4. 3.1.3 Imaging Center
  5. 3.2 Global Cardiac AI-assisted Diagnosis Market Size by Application
  6. 3.2.1 Global Cardiac AI-assisted Diagnosis Market Size Overview by Application (2021-2032)
  7. 3.2.2 Global Cardiac AI-assisted Diagnosis Historic Market Size Review by Application (2021-2026)
  8. 3.2.3 Global Cardiac AI-assisted Diagnosis Market Size Forecasted by Application (2027-2032)
  9. 3.3 Global Cardiac AI-assisted Diagnosis Market Size by Regions
  10. 3.3.1 North America Cardiac AI-assisted Diagnosis Market Size Breakdown by Application (2021-2026)
  11. 3.3.2 Europe Cardiac AI-assisted Diagnosis Market Size Breakdown by Application (2021-2026)
  12. 3.3.3 Asia-Pacific Cardiac AI-assisted Diagnosis Market Size Breakdown by Application (2021-2026)
  13. 3.3.4 South America Cardiac AI-assisted Diagnosis Market Size Breakdown by Application (2021-2026)
  14. 3.3.5 Middle East and Africa Cardiac AI-assisted Diagnosis Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
  1. 4.1 Cardiac AI-assisted Diagnosis Industry Trends
  2. 4.2 Cardiac AI-assisted Diagnosis Industry Drivers
  3. 4.3 Cardiac AI-assisted Diagnosis Industry Opportunities and Challenges
  4. 4.4 Cardiac AI-assisted Diagnosis Industry Restraints
5 Competitive Insights by Company
  1. 5.1 Global Top Players by Cardiac AI-assisted Diagnosis Revenue (2021-2026)
  2. 5.2 Global Cardiac AI-assisted Diagnosis Industry Company Ranking, 2024 VS 2025 VS 2026
  3. 5.3 Global Cardiac AI-assisted Diagnosis Key Company Headquarters & Area Served
  4. 5.4 Global Cardiac AI-assisted Diagnosis Company, Product Type & Application
  5. 5.5 Global Cardiac AI-assisted Diagnosis Company Commercialization Time
  6. 5.6 Market Competitive Analysis
  7. 5.6.1 Global Cardiac AI-assisted Diagnosis Market CR5 and HHI
  8. 5.6.2 Global Top 5 and 10 Cardiac AI-assisted Diagnosis Players Market Share by Revenue in 2025
  9. 5.6.3 2025 Cardiac AI-assisted Diagnosis Tier 1, Tier 2, and Tier 3
6 Company Profiles
  1. 6.1 Lepu Medical
  2. 6.1.1 Lepu Medical Company Information
  3. 6.1.2 Lepu Medical Business Overview
  4. 6.1.3 Lepu Medical Cardiac AI-assisted Diagnosis Revenue, Global Share and Gross Margin (2021-2026)
  5. 6.1.4 Lepu Medical Cardiac AI-assisted Diagnosis Product Portfolio
  6. 6.1.5 Lepu Medical Recent Developments
  7. 6.2 G K Healthcare
  8. 6.2.1 G K Healthcare Company Information
  9. 6.2.2 G K Healthcare Business Overview
  10. 6.2.3 G K Healthcare Cardiac AI-assisted Diagnosis Revenue, Global Share and Gross Margin (2021-2026)
  11. 6.2.4 G K Healthcare Cardiac AI-assisted Diagnosis Product Portfolio
  12. 6.2.5 G K Healthcare Recent Developments
  13. 6.3 Sense Time
  14. 6.3.1 Sense Time Company Information
  15. 6.3.2 Sense Time Business Overview
  16. 6.3.3 Sense Time Cardiac AI-assisted Diagnosis Revenue, Global Share and Gross Margin (2021-2026)
  17. 6.3.4 Sense Time Cardiac AI-assisted Diagnosis Product Portfolio
  18. 6.3.5 Sense Time Recent Developments
  19. 6.4 United Imaging
  20. 6.4.1 United Imaging Company Information
  21. 6.4.2 United Imaging Business Overview
  22. 6.4.3 United Imaging Cardiac AI-assisted Diagnosis Revenue, Global Share and Gross Margin (2021-2026)
  23. 6.4.4 United Imaging Cardiac AI-assisted Diagnosis Product Portfolio
  24. 6.4.5 United Imaging Recent Developments
  25. 6.5 Infervision
  26. 6.5.1 Infervision Company Information
  27. 6.5.2 Infervision Business Overview
  28. 6.5.3 Infervision Cardiac AI-assisted Diagnosis Revenue, Global Share and Gross Margin (2021-2026)
  29. 6.5.4 Infervision Cardiac AI-assisted Diagnosis Product Portfolio
  30. 6.5.5 Infervision Recent Developments
  31. 6.6 Shukun
  32. 6.6.1 Shukun Company Information
  33. 6.6.2 Shukun Business Overview
  34. 6.6.3 Shukun Cardiac AI-assisted Diagnosis Revenue, Global Share and Gross Margin (2021-2026)
  35. 6.6.4 Shukun Cardiac AI-assisted Diagnosis Product Portfolio
  36. 6.6.5 Shukun Recent Developments
  37. 6.7 FOSUN AITROX
  38. 6.7.1 FOSUN AITROX Company Information
  39. 6.7.2 FOSUN AITROX Business Overview
  40. 6.7.3 FOSUN AITROX Cardiac AI-assisted Diagnosis Revenue, Global Share and Gross Margin (2021-2026)
  41. 6.7.4 FOSUN AITROX Cardiac AI-assisted Diagnosis Product Portfolio
  42. 6.7.5 FOSUN AITROX Recent Developments
  43. 6.8 NANO-X
  44. 6.8.1 NANO-X Company Information
  45. 6.8.2 NANO-X Business Overview
  46. 6.8.3 NANO-X Cardiac AI-assisted Diagnosis Revenue, Global Share and Gross Margin (2021-2026)
  47. 6.8.4 NANO-X Cardiac AI-assisted Diagnosis Product Portfolio
  48. 6.8.5 NANO-X Recent Developments
  49. 6.9 MyCardium AI
  50. 6.9.1 MyCardium AI Company Information
  51. 6.9.2 MyCardium AI Business Overview
  52. 6.9.3 MyCardium AI Cardiac AI-assisted Diagnosis Revenue, Global Share and Gross Margin (2021-2026)
  53. 6.9.4 MyCardium AI Cardiac AI-assisted Diagnosis Product Portfolio
  54. 6.9.5 MyCardium AI Recent Developments
  55. 6.10 VUNO
  56. 6.10.1 VUNO Company Information
  57. 6.10.2 VUNO Business Overview
  58. 6.10.3 VUNO Cardiac AI-assisted Diagnosis Revenue, Global Share and Gross Margin (2021-2026)
  59. 6.10.4 VUNO Cardiac AI-assisted Diagnosis Product Portfolio
  60. 6.10.5 VUNO Recent Developments
  61. 6.11 Caption Care
  62. 6.11.1 Caption Care Company Information
  63. 6.11.2 Caption Care Business Overview
  64. 6.11.3 Caption Care Cardiac AI-assisted Diagnosis Revenue, Global Share and Gross Margin (2021-2026)
  65. 6.11.4 Caption Care Cardiac AI-assisted Diagnosis Product Portfolio
  66. 6.11.5 Caption Care Recent Developments
  67. 6.12 UltraSight
  68. 6.12.1 UltraSight Company Information
  69. 6.12.2 UltraSight Business Overview
  70. 6.12.3 UltraSight Cardiac AI-assisted Diagnosis Revenue, Global Share and Gross Margin (2021-2026)
  71. 6.12.4 UltraSight Cardiac AI-assisted Diagnosis Product Portfolio
  72. 6.12.5 UltraSight Recent Developments
  73. 6.13 Ultromics
  74. 6.13.1 Ultromics Company Information
  75. 6.13.2 Ultromics Business Overview
  76. 6.13.3 Ultromics Cardiac AI-assisted Diagnosis Revenue, Global Share and Gross Margin (2021-2026)
  77. 6.13.4 Ultromics Cardiac AI-assisted Diagnosis Product Portfolio
  78. 6.13.5 Ultromics Recent Developments
  79. 6.14 Cleerly
  80. 6.14.1 Cleerly Company Information
  81. 6.14.2 Cleerly Business Overview
  82. 6.14.3 Cleerly Cardiac AI-assisted Diagnosis Revenue, Global Share and Gross Margin (2021-2026)
  83. 6.14.4 Cleerly Cardiac AI-assisted Diagnosis Product Portfolio
  84. 6.14.5 Cleerly Recent Developments
  85. 6.15 Elucid
  86. 6.15.1 Elucid Company Information
  87. 6.15.2 Elucid Business Overview
  88. 6.15.3 Elucid Cardiac AI-assisted Diagnosis Revenue, Global Share and Gross Margin (2021-2026)
  89. 6.15.4 Elucid Cardiac AI-assisted Diagnosis Product Portfolio
  90. 6.15.5 Elucid Recent Developments
  91. 6.16 DiA Imaging Analysis
  92. 6.16.1 DiA Imaging Analysis Company Information
  93. 6.16.2 DiA Imaging Analysis Business Overview
  94. 6.16.3 DiA Imaging Analysis Cardiac AI-assisted Diagnosis Revenue, Global Share and Gross Margin (2021-2026)
  95. 6.16.4 DiA Imaging Analysis Cardiac AI-assisted Diagnosis Product Portfolio
  96. 6.16.5 DiA Imaging Analysis Recent Developments
  97. 6.17 Koninklijke Philips N.V
  98. 6.17.1 Koninklijke Philips N.V Company Information
  99. 6.17.2 Koninklijke Philips N.V Business Overview
  100. 6.17.3 Koninklijke Philips N.V Cardiac AI-assisted Diagnosis Revenue, Global Share and Gross Margin (2021-2026)
  101. 6.17.4 Koninklijke Philips N.V Cardiac AI-assisted Diagnosis Product Portfolio
  102. 6.17.5 Koninklijke Philips N.V Recent Developments
  103. 6.18 Fujifilm
  104. 6.18.1 Fujifilm Company Information
  105. 6.18.2 Fujifilm Business Overview
  106. 6.18.3 Fujifilm Cardiac AI-assisted Diagnosis Revenue, Global Share and Gross Margin (2021-2026)
  107. 6.18.4 Fujifilm Cardiac AI-assisted Diagnosis Product Portfolio
  108. 6.18.5 Fujifilm Recent Developments
7 North America
  1. 7.1 North America Cardiac AI-assisted Diagnosis Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 7.2 North America Cardiac AI-assisted Diagnosis Market Size by Country (2021-2026)
  3. 7.3 North America Cardiac AI-assisted Diagnosis Market Size Forecast by Country (2027-2032)
8 Europe
  1. 8.1 Europe Cardiac AI-assisted Diagnosis Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 8.2 Europe Cardiac AI-assisted Diagnosis Market Size by Country (2021-2026)
  3. 8.3 Europe Cardiac AI-assisted Diagnosis Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
  1. 9.1 Asia-Pacific Cardiac AI-assisted Diagnosis Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 9.2 Asia-Pacific Cardiac AI-assisted Diagnosis Market Size by Country (2021-2026)
  3. 9.3 Asia-Pacific Cardiac AI-assisted Diagnosis Market Size Forecast by Country (2027-2032)
10 South America
  1. 10.1 South America Cardiac AI-assisted Diagnosis Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 10.2 South America Cardiac AI-assisted Diagnosis Market Size by Country (2021-2026)
  3. 10.3 South America Cardiac AI-assisted Diagnosis Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
  1. 11.1 Middle East & Africa Cardiac AI-assisted Diagnosis Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 11.2 Middle East & Africa Cardiac AI-assisted Diagnosis Market Size by Country (2021-2026)
  3. 11.3 Middle East & Africa Cardiac AI-assisted Diagnosis Market Size Forecast by Country (2027-2032)
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst